ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of Physician’s Choice in Pts With HER2-Low Unresectable/Metastatic BC
By
ecancer
FEATURING
Shanu Modi
By
ecancer
FEATURING
Shanu Modi
Comments 0
Login to view comments.
Click here to Login
